Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Divestments (2017 - 2022)

Historic Divestments for Integra Lifesciences Holdings (IART) over the last 6 years, with Q3 2022 value amounting to $24.0 million.

  • Integra Lifesciences Holdings' Divestments rose 198958.99% to $24.0 million in Q3 2022 from the same period last year, while for Dec 2023 it was $24.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $24.0 million for FY2022, which is 8742.05% down from last year.
  • According to the latest figures from Q3 2022, Integra Lifesciences Holdings' Divestments is $24.0 million, which was up 198958.99% from -$1.3 million recorded in Q3 2021.
  • Integra Lifesciences Holdings' 5-year Divestments high stood at $191.7 million for Q1 2021, and its period low was -$1.3 million during Q3 2021.
  • Over the past 3 years, Integra Lifesciences Holdings' median Divestments value was $14.8 million (recorded in 2018), while the average stood at $55.0 million.
  • Per our database at Business Quant, Integra Lifesciences Holdings' Divestments surged by 10294.95% in 2018 and then soared by 198958.99% in 2022.
  • Quarter analysis of 3 years shows Integra Lifesciences Holdings' Divestments stood at $5.7 million in 2018, then crashed by 122.17% to -$1.3 million in 2021, then soared by 1989.59% to $24.0 million in 2022.
  • Its Divestments was $24.0 million in Q3 2022, compared to -$1.3 million in Q3 2021 and $191.7 million in Q1 2021.